Litcius/Paper detail

Pulmonary immuno-thrombosis in COVID-19 ARDS pathogenesis

James S. O’Donnell, Flora Peyvandi, Ignacio Martín‐Loeches

2021Intensive Care Medicine51 citationsDOIOpen Access PDF

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) is responsible for coronavirus disease 2019\n(COVID-19). Recent data highlight a pivotal role for pulmonary immuno-thrombosis in COVID-19 in the pathogenesis of severe COVID-19.

Topics & Concepts

MedicineARDSPathogenesisCoronavirus disease 2019 (COVID-19)Coronavirus2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ThrombosisRespiratory diseaseIntensive care medicineDiseaseVirologyLungImmunologyPathologyInternal medicineInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Inflammasome and immune disorders
Pulmonary immuno-thrombosis in COVID-19 ARDS pathogenesis | Litcius